Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Integra LifeSciences Holdings Corporation logo

Integra LifeSciences Holdings Corporation

Sector: Healthcare   

Industry: Medical Devices

35.45
 
USD
  
0.62
  
(1.78%)
Optionable: Yes  Market Cap: 2,640 M  90-day average vol: 651,326

Previous close: 34.83  Open: 34.76  Bid: 34.76  Ask: 36.09
52 week range    
33.24   
   59.33
Peers   
SYK / 
TFX / 
XRAY / 
CNMD / 
JNJ / 
MDT / 
Last updated: Friday 29th March 2024
56
MarketXLS Rank
60
Value
46
Technical
63
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

IART Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles13 M7 M10 M14 M20 M21 M27 M28 M17 M14 M
Basic EPS from continuing operations0.20.270.10.50.84
Basic EPS total-0.30.530.210.50.840.730.591.582.02.18
Basic weighted shares outstanding57 M65 M69 M149 M77 M83 M86 M85 M85 M83 M
BasicDiscontinuousOperations0.27-0.15
Cost of sales-327 M-303 M-327 M-349 M-436 M-571 M-565 M-521 M-598 M-587 M
Depreciation-28 M-24 M-27 M-31 M-36 M-44 M-43 M-42 M-39 M-40 M
Depreciation unreconciled13 M7 M10 M14 M20 M21 M27 M28 M17 M14 M
DepreciationAndAmortization13 M7 M10 M14 M20 M21 M27 M28 M17 M14 M
Diluted EPS total-0.30.520.20.470.820.720.581.571.982.16
Diluted normalized net income/share0.20.260.10.470.82
Diluted weighted shares outstanding57 M66 M71 M158 M79 M84 M86 M85 M85 M84 M
DilutedDiscontinuousOperations0.26-0.15
GainOnSaleOfBusiness-602000.0102000.042 M644000.0
GainOnSaleOfSecurity-2 M3 M455000.01 M
GeneralAndAdministrativeExpense-255 M-231 M-10 M-10 M-13 M-16 M-20 M-20 M-20 M-23 M
Gross operating profit509 M494 M556 M643 M753 M901 M953 M851 M945 M970 M
ImpairmentOfCapitalAssets47 M-3 M-5 M-6 M
Income before tax-31 M46 M61 M90 M11 M57 M60 M94 M215 M214 M
Income restructuring and M&A7 M-41 M-11 M-28 M-82 M336000.012 M
Income taxes-10 M9 M54 M16 M-53 M-3 M10 M-40 M46 M33 M
Interest income443000.0168000.030000.024000.0255000.03 M11 M9 M7 M12 M
InterestExpenseNonOperating20 M22 M24 M26 M35 M65 M54 M72 M50 M50 M
InterestExpenseOperating-9 M-11 M-13 M-14 M-32 M-58 M-49 M-47 M-43 M-42 M
MiscOtherSpecialCharges-2 M-492000.05 M845000.01 M8 M10 M4 M19 M12 M
Net income from total operations-21 M36 M7 M75 M65 M61 M50 M134 M169 M181 M
NetIncomeCommonStockholders-21 M36 M7 M75 M65 M61 M50 M134 M169 M181 M
NetIncomeContinuousOperations-21 M36 M7 M75 M65 M61 M50 M134 M169 M181 M
NetIncomeDiscontinuousOperations-2 M-10 M
NetNonOperatingInterestIncomeExpense-19 M-22 M-24 M-26 M-35 M-62 M-43 M-62 M-44 M-38 M
Operating income37 M68 M80 M115 M45 M111 M94 M151 M197 M239 M
Operating income before depreciation (EBITDA)28 M106 M133 M177 M106 M181 M175 M234 M342 M382 M
OperatingExpense473 M426 M477 M528 M708 M790 M859 M700 M747 M731 M
Other income net2 M492000.0-5 M-845000.0-1 M-8 M-10 M-4 M-61 M-13 M
OtherGandA-255 M-231 M-10 M-10 M-13 M-16 M-20 M-20 M-20 M-23 M
OtherImpairmentOfCapitalAssets-7 M
OtherOperatingExpenses-346000.0-400000.0-2 M-762000.0-12 M-4 M-15 M
RentAndLandingFees-10 M-10 M-10 M-10 M-13 M-16 M
Research & development expense52 M44 M51 M58 M63 M78 M144 M77 M93 M101 M
ResearchExpense52 M44 M51 M58 M63 M78 M144 M77 M93 M101 M
RestructringAndMnAIncome7 M-41 M-11 M-28 M-82 M336000.012 M
Revenue per share13 M7 M10 M14 M20 M21 M27 M28 M17 M14 M
SalariesAndWages-10 M-15 M-15 M-17 M-22 M-21 M-21 M-20 M-36 M-28 M
Selling Gen & administrative expense408 M376 M416 M456 M624 M691 M688 M595 M637 M616 M
SellingAndMarketingExpense408 M376 M416 M456 M624 M691 M688 M595 M637 M616 M
SellingExpense408 M376 M416 M456 M624 M691 M688 M595 M637 M616 M
Special income/charges-47 M41 M11 M28 M88 M5 M6 M-336000.0-12 M
Total Income available for interest expense (EBIT)-21 M57 M72 M102 M14 M64 M65 M118 M222 M263 M
Total common shares outstanding65 M66 M74 M150 M78 M85 M84 M84 M83 M82 M
Total net income-21 M36 M7 M75 M65 M61 M50 M134 M169 M181 M
Total ordinary shares78 M78 M78 M78 M78 M78 M78 M78 M78 M78 M
Total revenues836 M797 M883 M992 M1,188 M1,472 M1,518 M1,372 M1,542 M1,558 M
TotalExpenses146 M123 M150 M179 M272 M218 M294 M179 M150 M144 M
TotalRevenue697 M797 M883 M992 M1,188 M1,472 M1,518 M1,372 M1,542 M1,558 M
WriteDown-3 M-5 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University